We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Scientific correspondence discusses TyG-VLR biomarker utility for cardiovascular-kidney-metabolic syndrome, highlighting composite metabolic indices in risk assessment.
1 2 9 3 3 -0 2 6 -0 3 3 3 8
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: